TENNOR THERAP-B(06872.HK)

We are a biotech company approaching the commercialization stage, focused on discovering, developing, and commercializing differentiated innovative drug products to address clinical needs in the areas of bacterial infection and bacteria metabolism-related diseases. Leveraging our multi-target conjugated molecular technology, we are committed to providing patients with optimal treatment solutions to overcome the limitations of traditional therapies and improve patient outcomes.